The maximum standardized uptake value increment calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography predicts survival in patients with oral tongue squamous cell carcinoma

被引:10
|
作者
Yonezawa, Natsuki [1 ]
Minamikawa, Tsutomu [1 ]
Kitajima, Kazuhiro [2 ,3 ]
Takahashi, Yusuke [1 ]
Sasaki, Ryohei [4 ]
Nibu, Ken-ichi [5 ]
Komori, Takahide [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan
[2] Hyogo Coll Med, Dept Radiol, Div Nucl Med, Nishinomiya, Hyogo, Japan
[3] Hyogo Coll Med, PET Ctr, Nishinomiya, Hyogo, Japan
[4] Kobe Univ, Grad Sch Med, Div Radiat Oncol, Kobe, Hyogo, Japan
[5] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan
来源
NAGOYA JOURNAL OF MEDICAL SCIENCE | 2017年 / 79卷 / 02期
关键词
Oral tongue squamous cell carcinoma; Dual-time-point F-18-FDG PET; Standardized uptake value; PET parameters; Prognosis; PHASE F-18-FDG PET; PROGNOSTIC VALUE; FDG-PET; HEAD; CANCER; EPIDEMIOLOGY; PARAMETERS; VOLUME;
D O I
10.18999/nagjms.79.2.189
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to investigate the prognostic value of dual-time-point (DTP) F-18-fluorode-oxyglucose positron emission tomography (F-18-FDG PET) imaging in primary oral tongue squamous cell carcinoma (OTSCC). The study included 52 patients who underwent preoperative F-18-FDG PET scans at two time points, namely 1 h and 2 h after injection. The following PET parameters were calculated: maximum standardized uptake value (SUVmax) for both time points (SUV early, SUV delayed); retention index (RI); and SUVmax increment (Delta SUVmax). Receiver operating characteristic (ROC) curve analysis was performed to define the optimal cutoff point for these parameters. Overall survival was calculated using the Kaplan-Meier method. Prognostic factors for patients with OTSCC were evaluated using the univariate log-rank test and a multivariate Cox proportional hazards model. ROC analysis revealed that the area under the curve was higher and more accurate for Delta SUVmax than for the other parameters. Additionally, patients with a Delta SUVmax >= 0.9 had significantly worse survival outcomes (28.9% vs 92.6%; p < 0.01). Univariate analysis showed that prognosis was significantly correlated with clinical T stage, local recurrence, perineural invasion, vascular invasion, and PET parameters (p < 0.05 for all). Multivariate analysis showed that local recurrence (hazard ratio = 3.60; p = 0.02) and Delta SUVmax (hazard ratio = 8.43; p < 0.01) were independent prognostic factors. Delta SUVmax determined using DTP F-18-FDG PET may be an additional prognostic factor in OTSCC patients.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [1] Prognostic value of the standardized uptake value maximum change calculated by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging in patients with advanced non-small-cell lung cancer
    Jin, Feng
    Zhu, Hui
    Fu, Zheng
    Kong, Li
    Yu, Jinming
    ONCOTARGETS AND THERAPY, 2016, 9 : 2993 - 2999
  • [2] Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis
    Umeda, Yukihiro
    Demura, Yoshiki
    Morikawa, Miwa
    Ameshima, Shingo
    Tsuchida, Tatsuro
    Fujibayashi, Yasuhisa
    Okazawa, Hidehiko
    Ishizaki, Takeshi
    RESPIROLOGY, 2011, 16 (04) : 713 - 720
  • [3] Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer
    Kuwabara, Hirofumi
    Toriihara, Akira
    Yuasa-Nakagawa, Keiko
    Toda, Kazuma
    Tateishi, Ukihide
    Yoshimura, Ryoichi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (01): : 103 - 109
  • [4] Preoperative 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection
    Römer, W
    Kuwert, T
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (03) : 208 - 209
  • [5] Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Usefulness of standardized uptake value and retention index
    Kwon, Yeongkeun
    Park, Eunkyung
    Pahk, Kisoo
    Kim, Sungeun
    Kim, Min Ju
    Graf, Daniel
    Park, Sungsoo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (01) : 142 - 147
  • [6] 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
    Binderup, Tina
    Knigge, Ulrich
    Loft, Annika
    Federspiel, Birgitte
    Kjaer, Andreas
    CLINICAL CANCER RESEARCH, 2010, 16 (03) : 978 - 985
  • [7] Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma
    Rhu, Jinsoo
    Hyun, Seung Hyup
    Lee, Kyung-Han
    Jo, Sung Jun
    Lee, Kyo Won
    Park, Jae Berm
    Kim, Sung Joo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] Maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma
    Jinsoo Rhu
    Seung Hyup Hyun
    Kyung-Han Lee
    Sung Jun Jo
    Kyo Won Lee
    Jae Berm Park
    Sung Joo Kim
    Scientific Reports, 9
  • [9] Genomic Signature of the Standardized Uptake Value in 18F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer
    Kim, Seon-Kyu
    Ahn, Sung Gwe
    Mun, Jeong-Yeon
    Jeong, Mi-So
    Bae, Soong June
    Lee, Ju-Seog
    Jeong, Joon
    Leem, Sun-Hee
    Chu, In-Sun
    CANCERS, 2020, 12 (02)
  • [10] The Diagnostic and Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Laryngeal Squamous Cell Carcinoma
    Al-Ibraheem, Akram
    Abdlkadir, Ahmed Saad
    Shagera, Qaid Ahmed
    Saraireh, Omar
    Al-Adhami, Dhuha
    Al-Rashdan, Rakan
    Anwar, Farah
    Moghrabi, Serin
    Mohamad, Issa
    Muylle, Kristoff
    Estrada, Enrique
    Paez, Diana
    Mansour, Asem
    Lopci, Egesta
    CANCERS, 2023, 15 (22)